ejdoli
Long

VVUS hits a bottom. Breaking out of falling wedge formation

NASDAQ:VVUS   VIVUS INC
89 0 0
- Qysmia looks to be gaining from new online marketing efforts
- Endo             will start promoting Vivus' ED drug
- 36% short interest!
- Institutional investors adding at these levels
- Recently hit a 10-year-low, but things have never looked brighter for VVUS            

PT: $10
Timeframe: 18 - 24 months (possibly sooner, depending on how ED drug sales are)

Disclosure: Long $2 Jan 2017 calls @1.10/contract
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out